Literature DB >> 14871805

TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).

Akash Nanda1, Eleanor B Carson-Walter, Steven Seaman, Thomas D Barber, Jason Stampfl, Sujay Singh, Bert Vogelstein, Kenneth W Kinzler, Brad St Croix.   

Abstract

Tumor endothelial marker (TEM)8 was uncovered as a gene expressed predominantly in tumor endothelium, and its protein product was recently identified as the receptor for anthrax toxin. Here, we demonstrate that TEM8 protein is preferentially expressed in endothelial cells of neoplastic tissue. We used the extracellular domain of TEM8 to search for ligands and identified the alpha 3 subunit of collagen VI as an interacting partner. The TEM8-interacting region on collagen alpha 3(VI) was mapped to its COOH-terminal C5 domain. Remarkably, collagen alpha 3(VI) is also preferentially expressed in tumor endothelium in a pattern concordant with that of TEM8. These results suggest that the TEM8/C5 interaction may play an important biological role in tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871805     DOI: 10.1158/0008-5472.can-03-2408

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  90 in total

1.  Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1.

Authors:  Lin Cao; Ran Zhang; Tingting Liu; Zixian Sun; Mingxu Hu; Yuna Sun; Lingpeng Cheng; Yu Guo; Sheng Fu; Junjie Hu; Xiangmin Li; Chengqi Yu; Hanyang Wang; Huanchun Chen; Xueming Li; Elizabeth E Fry; David I Stuart; Ping Qian; Zhiyong Lou; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Binding of filamentous actin to anthrax toxin receptor 1 decreases its association with protective antigen.

Authors:  Kristopher M Garlick; Sarah Batty; Jeremy Mogridge
Journal:  Biochemistry       Date:  2012-02-03       Impact factor: 3.162

3.  Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.

Authors:  Kuang-Hua Chen; Shihui Liu; Laurie A Bankston; Robert C Liddington; Stephen H Leppla
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

4.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

5.  C-terminal proteolysis of the collagen VI α3 chain by BMP-1 and proprotein convertase(s) releases endotrophin in fragments of different sizes.

Authors:  Stefanie Elisabeth Heumüller; Maya Talantikite; Manon Napoli; Jean Armengaud; Matthias Mörgelin; Ursula Hartmann; Gerhard Sengle; Mats Paulsson; Catherine Moali; Raimund Wagener
Journal:  J Biol Chem       Date:  2019-07-25       Impact factor: 5.157

6.  Expression profile of tumor endothelial marker 7 and a putative ligand in the rat spinal cord and dorsal root ganglion.

Authors:  Lih Wang; Kyu-Yeol Lee; Hwan-Tae Park; Dong-Sik Kang
Journal:  Asian Spine J       Date:  2007-12-31

7.  The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.

Authors:  Sheng Fu; Xiaohang Tong; Chenguang Cai; Ying Zhao; Yang Wu; Yuanyuan Li; Junjie Xu; Xuejun C Zhang; Long Xu; Wei Chen; Zihe Rao
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

Review 8.  Targeting of drugs and nanoparticles to tumors.

Authors:  Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

9.  The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.

Authors:  K Gaballah; R Oakley; A Hills; A Ryan; M Partridge
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.

Authors:  C V Reeves; J Dufraine; J A T Young; J Kitajewski
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.